A 2020 study in Molecular Cancer Therapeutics by Riches et al. details the pharmacology of the ATM inhibitor AZD0156, noting its ability to potentiate irradiation and olaparib responses in preclinical models.

Authors

• Person: Not available Organization: Nature
  Perspectives on cancer therapy—synthetic lethal precision medicine ...

Sources

• Perspectives on cancer therapy—synthetic lethal precision medicine ... www.nature.com Nature via serper

Referenced by nodes (1)

• olaparib concept